Clinical Study
A Postauthorization Survey to Document the Therapeutic Management of Oxaliplatin as a First-Line Chemotherapy Regimen in South Africa in Patients with Metastatic Colorectal Cancer
Table 5
Causes of death at 30 days after oxaliplatin treatment discontinuation.
| ||||||||||||||||||||
The percentage is calculated out of 195, the total number of patients in the survey’s cohort. |